Combination NTI Drugs and Generic Availability: Coverage and Gaps
Combination NTI drugs carry high risks when switched to generics due to tight therapeutic windows. Despite cost savings, bioequivalence challenges and patient safety concerns limit availability, creating major gaps in affordable treatment options.